Western Australian marsupials are multiply infected with genetically diverse strains of Toxoplasma gondii by Pan, S. et al.
Western Australian Marsupials Are Multiply Infected with
Genetically Diverse Strains of Toxoplasma gondii
Shuting Pan
1, R. C. Andrew Thompson
1, Michael E. Grigg
2, Natarajan Sundar
2, Andrew Smith
1,
Alan J. Lymbery
3*
1School of Veterinary and Biomedical Sciences, Murdoch University, Perth, Western Australia, Australia, 2Molecular Parasitology Unit, Laboratory of Parasitic Diseases,
National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America, 3Fish Health Unit, School of Veterinary and Biomedical Sciences,
Murdoch University, Perth, Western Australia, Australia
Abstract
Five different organs from 16 asymptomatic free-ranging marsupial macropods (Macropus rufus, M. fuliginosus, and M.
robustus) from inland Western Australia were tested for infection with Toxoplasma gondii by multi-locus PCR-DNA
sequencing. All macropods were infected with T. gondii, and 13 had parasite DNA in at least 2 organs. In total, 45 distinct T.
gondii genotypes were detected. Fourteen of the 16 macropods were multiply infected with genetically distinct T. gondii
genotypes that often partitioned between different organs. The presence of multiple T. gondii infections in macropods
suggests that native mammals have the potential to promote regular cycles of sexual reproduction in the definitive felid
host in this environment.
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Introduction
Toxoplasma gondii is a ubiquitous intracellular protozoan parasite
of endothermic vertebrates including humans. Domestic cats (Felis
catus) and other members of the family Felidae are the definitive
host of T. gondii and pass environmentally resistant oocysts in the
faeces, which are infective on ingestion to a wide range of
intermediate hosts [1]. Following ingestion, oocysts release
sporozoites which invade the gut epithelium and transform into
tachyzoites, which then multiply rapidly through asexual repro-
duction and colonize many host tissues, evoking a strong immune
response. Tachyzoites differentiate into persistent, slow-growing
bradyzoites, a form that produces thick-walled tissue cysts,
impervious to the immune response induced by tachyzoites.
Bradyzoites are transmitted to either a definitive, or another
intermediate host upon ingestion of infected tissues [1].
Despite the existence of a sexual phase in the life cycle,
population genetic studies of T. gondii in Europe and North
America have identified a remarkably clonal population structure,
with three predominant clonal lineages, referred to as types I, II
and III, accounting for over 84% of strains isolated largely from
symptomatic humans and domestic animals [2]. More recently, a
fourth lineage (designated haplogroup 12) was identified, princi-
pally infecting wild animals in sylvatic niches of North America
[3]. The capacity of this parasite to be transmitted asexually by
carnivory [4], and the apparent rarity of mixed strain T. gondii co-
infections among prey species of the definitive felid host (which
would promote only self-fertilisation during the sexual cycle), have
been interpreted to explain the clonal population genetic structure
found in these two regions [5–7].
Recent studies of T. gondii, especially in wildlife, but also in
domestic hosts from parts of the world other than North America
and Europe, have reported more genetic diversity [8–10].
Although some strains found in these areas appear to be
recombinant genotypes derived from crosses between the arche-
typal clonal lineages, others possess completely novel alleles and
are usually referred to as ‘‘atypical’’ or ‘‘exotic’’ strains [11]. It has
been suggested that this diversity is driven by regular cycles of
sexual reproduction and outcrossing in areas where wildlife plays a
more significant role in transmission of the parasite [8,12,13].
Even in this situation, however, recent evidence suggests that self-
fertilisation is an important step leading to the epidemic expansion
and transmission of newly emerged parasite clones [14].
The relative rates of outcrossing and selfing in T. gondii are likely
to be determined by the frequency of multiple infections (i.e.
simultaneous infections with two or more strains) in intermediate
hosts, which are subsequently preyed upon by cats. Multiple
infections are considered relatively rare events because strong
immunity developed in intermediate hosts during primary
infections with T. gondii is thought to preclude infection with
another strain of the parasite [6]. However, concurrent infection
with different strains of T. gondii is possible, and has been shown to
occur in experimental animals [15]. We recently had the
opportunity to examine T. gondii infections in macropod marsu-
pials (kangaroos, wallaroos and wallabies) sampled from a small,
defined geographic area in Western Australia. Our aim was to use
direct sequencing of tissue samples to determine the frequency of
multiple infections and to examine the genetic diversity of the
parasite.
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A total of 16 individual adult macropods from three species,
Macropus rufus, M. fuliginous and M. robustus, were sampled in 2008
during a routine cull of wild animals by a licensed shooter on a
farming property near Menzies, Western Australia (29u419S,
121u029E). None of the macropods had any overt clinical
symptoms. Tissue samples were collected from five organs (heart,
liver, lung, spleen and diaphragm) from each macropod. To avoid
any chance of cross-contamination, each organ was first separated
from the body and placed into a labelled sterile plastic bag.
Multiple 5 g samples were excised, placed into 5 ml sterile tubes
for tissue extractions, and samples were analysed at two different
laboratories (one at Murdoch University in Australia, one at NIH
in the USA) to control for the possibility of spurious amplification
during direct PCR on DNA extracted from these tissue samples.
All samples were stored at 280uC prior to extraction.
DNA was extracted using the QIAamp Mini Kit (Qiagen; www.
qiagen.com), following the manufacturers protocol. Nested PCR
was used to amplify the markers B1, SAG2 and SAG3 [10]. Each
25 ml PCR reaction mixture contained 2.5 mlo f1 0 6PCR buffer,
25 mM MgCl2, 0.1 mM deoxynucleoside triphosphate mix
(dNTP set-Promega), 5 pmol of each primer, and 0.75 U of
TTH plus DNA polymerase. Cycle conditions for the two rounds
of PCRs for the B1 gene were: initial 95uC for 5 min, followed by
30 cycles of 94uC for 30 s, 60uC for 30 s, and 72uC for 90 s. For
SAG2, the annealing temperatures were 65uC and 63uC for the
first and second round respectively, and both rounds ran for 35
cycles. For SAG3, the annealing temperature was 60uC and 35
cycles were run for both rounds. The second round PCR used 1 ml
of first round reaction, diluted 1:20, as template. The final PCR
product was separated on a 1.5% agarose gel and visualised by
staining with i-sybersafe-s33102. Negative PCR controls (i.e. not
including template DNA) were included in all reactions, and
standard type I and type III template DNA used as positive
controls.
Tissue samples which amplified at one or more of the diagnostic
T. gondii markers were considered positive. Prevalence of parasite
infection was expressed as percentage of hosts with a positive DNA
sample and 95% confidence intervals were calculated assuming a
binomial distribution, using the software Quantitative Parasitology
3.0 [16]. Difference in prevalence among organs was tested by x
2.
PCR products from all samples were purified with the Wizsv
GEL & PCR or EXoSAP-IT Kits (GE Healthcare Life Sciences)
and sequencing reactions performed using a BigDye Terminator
v3.1 Cycle Sequencing Kit (Applied Biosystems, Scoresby,
Australia). All sequencing was conducted with an Applied
Biosystems 3730XL DNA analyser and sequence alignment was
conducted using Clustal W [17]. Following alignment, sequences
from all samples were compared with type I, II and III reference
isolates at the B1 locus (polymorphisms distinguish type I from
type II and III strains, which share the same allele), the SAG2 locus
(polymorphisms distinguish types I and II strains, which share the
same allele, from type III) and the SAG3 locus (polymorphisms
distinguish all three strains).
Results
Among the three loci that were tested, B1 showed the highest
sensitivity and detected T. gondii in 45 out of the total of 80 tissue
samples. Of these 45 samples, T. gondii was detected in 41 and 43
samples at the SAG2 and SAG3 loci, respectively. None of the
samples that were negative at the B1 locus tested positive with the
other loci. Using the B1 gene as a diagnostic marker, all 16
individual macropods were infected by T. gondii, with the parasite
detected in tissue samples from at least one organ (Table 1).
Thirteen of the macropods in our study had infections in more
than one organ, with all five organs infected in two macropods
(Table 1). Over all hosts, there was a significant difference in the
prevalence of T. gondii in the different organs that were tested
(x
2=9.65, P=0.04), with the highest infection rate in heart
(81.3%, 95% CI 56.4–94.7%), followed by spleen and diaphragm
(62.5%, 95% CI 37.2–82.2%), liver (43.8%, 95% CI 20.8–89.4%)
and lungs being least heavily infected (31.3% 95% CI 13.2–
56.4%).
Polymorphisms were detected at 29 single nucleotide positions
of the 530 bp B1 35 copy tandem gene array. All polymorphisms
were point substitutions, rather than insertions or deletions. Of 45
samples that were amplified and sequenced at the B1 locus, 34
different alleles were detected (Table S1). The sequence data
indicated that two samples had an allele identical to the type I
reference isolate, two had an allele identical to the type II/III
reference isolates, while 41 had non-archetypal alleles, with one or
more novel polymorphisms at the B1 locus (Table S1). In almost
all cases, these atypical alleles differed from the type I or type II/
III reference alleles by between one and three nucleotide positions
(Table S1). Two nucleotide peaks were detected in a number of
samples, and these presumably reflected polymorphisms within the
35 copy B1 gene array. Identical sequences for each unique allele
were obtained from independent extractions followed by PCR-
DNA sequencing in separate laboratories at Murdoch University
and NIH, indicating that it is very unlikely that the novel B1 alleles
were the result of a spurious amplification.
At the 471 bp SAG2 locus, substitutions were found at six single
nucleotide positions. Four different alleles were found among the
samples that were amplified at this locus; 16 samples had an allele
identical to the type I and II reference isolates, 26 samples had an
allele identical to the type III reference isolate, while two samples
had atypical alleles, differing at two and three nucleotide positions
from the archetypal type III allele (Table S2). Substitutions were
found at nine single nucleotide positions at the 225 bp SAG3 locus,
with five different alleles among the samples that were amplified at
this locus (Table S2). Seven samples had an allele identical to the
type I reference isolate, thirty two samples had an allele identical
to the type II reference isolate, 18 had an allele identical to the
type III reference isolate, while two had atypical alleles (Table S2).
Of these atypical alleles, one differed from the type II reference
allele at two nucleotide positions, while the other two differed from
the type I reference allele at two nucleotide positions.
Of the 45 different organs from which T. gondii could be
amplified at either the SAG2 or SAG3 locus, 18 (40%) showed
mixed nucleotides at one or more positions (Table S2). Three
samples had two nucleotide peaks (C and T) at position 40 of the
SAG2 locus, indicating the presence of both type I/II and type III
alleles, while one sample had two nucleotide peaks at positions 49
and 76 of the SAG2 locus, being a putative mixture of type III and
an atypical allele. Eighteen samples had two nucleotide peaks at a
number of positions of the SAG3 locus, with seven samples being
putative mixtures of types I and II alleles, ten being putative
mixtures of types II and III alleles and one being a putative
mixture of types I, II and III alleles. Because both SAG2 and SAG3
are single-copy genes, these di-nucleotide peaks were likely the
result of mixed infections with different genotypes of T. gondii in
the same organ. All samples with di-nucleotide peaks at either the
SAG2 or SAG3 locus were independently re-sequenced at Murdoch
University and NIH, with the same results being obtained. As a
test of our interpretation that di-nucleotide peaks represent mixed
infections, marsupial DNA was spiked with limiting concentrations
of DNA at a variety of ratios (i.e. 10:1, 1:1, 1:10) from a type I and
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five independent reactions. The resulting product was sent for
direct DNA sequencing of the PCR population. In all cases, both
alleles were amplified, and this was detected by the presence of di-
nucleotide peaks at the relevant polymorphic sites between the two
alleles (data not shown).
Table 2 shows the multi-locus genotypes at each of the three loci
which could be amplified for all samples. All except three samples
had non-archetypal alleles for at least one of the three loci that
were amplified. Fourteen samples showed evidence of recombi-
nation between archetypal genotypes, as they possessed different
inheritance patterns of archetypal lineage alleles at two or more
loci. Thirteen of the 16 macropods had infections in more than
one organ and, of these, all had different multilocus genotypes of
T. gondii in different organs, indicating multiple infections of
individual kangaroos (Table 2). Strict determination of the multi-
Table 1. Presence of Toxoplasma gondii in tissue samples from five different organs in 16 macropod marsupials of three species
(Macropus rufus, M. fuliginosus and M. robustus) tested by direct PCR.
Animal ID Species Organ Infected? Animal ID Species Organ Infected?
K-1 M. rufus Heart positive K-9 M. fuliginosus Heart positive
Liver negative Liver positive
Lung positive Lung negative
Spleen positive Spleen positive
Diaphragm positive Diaphragm positive
K-2 M. rufus Heart negative K-10 M. fuliginosus Heart positive
Liver positive Liver positive
Lung negative Lung negative
Spleen negative Spleen positive
Diaphragm positive Diaphragm positive
K-3 M. rufus Heart positive K-11 M. fuliginosus Heart positive
Liver positive Liver positive
Lung positive Lung positive
Spleen positive Spleen positive
Diaphragm positive Diaphragm positive
K-4 M. rufus Heart positive K-12 M. robustus Heart positive
Liver negative Liver negative
Lung negative Lung negative
Spleen positive Spleen positive
Diaphragm positive Diaphragm negative
K-5 M. rufus Heart negative K-13 M. robustus Heart positive
Liver negative Liver negative
Lung negative Lung negative
Spleen positive Spleen negative
Diaphragm negative Diaphragm positive
K-6 M. rufus Heart negative K-14 M. robustus Heart positive
Liver positive Liver negative
Lung negative Lung positive
Spleen negative Spleen positive
Diaphragm negative Diaphragm negative
K-7 M. fuliginosus Heart positive K-15 M. robustus Heart positive
Liver negative Liver negative
Lung negative Lung negative
Spleen positive Spleen negative
Diaphragm negative Diaphragm negative
K-8 M. fuliginosus Heart positive K-16 M. robustus Heart positive
Liver positive Liver negative
Lung negative Lung positive
Spleen negative Spleen negative
Diaphragm positive Diaphragm negative
doi:10.1371/journal.pone.0045147.t001
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number of mixed strain multiple infections detected.
Discussion
Studies of T. gondii in domestic cycles of transmission in Europe
and North America have typically found high rates of seroprev-
alence (.40%) in people, livestock and companion animals [7].
High prevalences have also been reported in wildlife in different
areas of the world, for example approximately 50% in wild boar
(Sus scrofa) in France [18], 60% in white-tailed deer (Odocoileus
virginianus) in the USA [19], 75% in capybara (Hydrochaeris
hydrochaeris) in Brazil [20] and 84% in black bears (Ursus americanus)
in the USA [21]. There have, however, been few studies of the
prevalence of T. gondii in either domestic or wildlife cycles in
Australia. In this study, we found that of 16 macropod marsupials
of three different species inhabiting a defined geographic area in
the arid rangelands of Western Australia, all were infected. This is
much greater than the prevalence found in three serological
studies on macropods in different areas of Australia; 8.5% among
Macropus rufogriseus and Thylogale billardierii in Tasmania [22],
15.5% and among Macropus fuliginosus in south western Australia
[23] and 5% among Petrogale penicillata in southeast Queensland
[24]. This suggests the need for serological studies on a larger
sample of macropods from our study site, to determine whether
our results are really reflective of a higher prevalence of T. gondii in
this region.
It has been suggested that Australian native mammals are
particularly prone to severe pathological effects when infected with
T. gondii, possibly from not being exposed to the parasite prior to
the introduction of domestic cats some 300 years ago [25]. In our
study, there were no clinical signs of toxoplasmosis in the wild
macropods sampled, despite a high prevalence of infection, often
in a number of different organs. This does not necessarily mean,
however, that the high infection rates found in these animals has
no implications for wildlife conservation in Australia. Virulence is
not a static property of a parasite’s genome and strains of T. gondii
that are avirulent in one host species may be virulent in another
[10]. In addition, most clinical cases of toxoplasmosis in Australian
wildlife have been in captive animals, suggesting that non-parasite
factors, such as immune or nutritional status of the host, also affect
virulence [10].
Macropods are herbivores, so presumably the source of
infection in this study was oocysts shed by definitive felid hosts,
probably feral cats (Felis catus), although vertical transmission has
also been reported in kangaroos [26] and may play a role in
maintaining the life cycle of T. gondii in this arid rangeland region.
The high prevalence of infection suggests heavy environmental
contamination of this area with oocysts. Feral cats are known to be
present in the area, and, although population size is not known,
studies in similar arid environments in Australia have estimated cat
densities at between 0.75 and 2.8 km
22 [27,28]. Recent studies in
our laboratory (data not shown) have confirmed T. gondii infection
in four feral cats sampled from the south west of Western
Table 2. Multi-locus genotypes of Toxoplasma gondii by direct PCR and sequencing of tissue samples from macropods.
Sample Alleles Genotype Sample Alleles Genotype
B1 SAG2 SAG3 B1 SAG2 SAG3
K1-Heart I NT II+III Recombinant/Mixed K9-Heart U-19 III II Recombinant
K1-Lung U-1 NT II+III Mixed K9-Liver U-20 U-1 II
K1-Spln U-2 III I+II Recombinant/Mixed K9-Spln U-17 I/II I+II+III Mixed
K1-Diaph U-3 I/II II K9-Diaph U-21 III II+III Mixed
K2-Liver U-4 III II Recombinant K10-Heart U-22 III III
K2-Diaph U-5 III III K10-Liver U-17 III II+III Mixed
K3-Heart U-6 III III K10-Spln U-23 III III
K3-Liver U-7 III III K10-Diaph U-24 III II Recombinant
K3-Lung II/III III II+III Mixed K11-Heart I NT U-1
K3-Spln U-8 I/II II+III Mixed K11-Liver U-25 II+III II+III Mixed
K3-Diaph U-9 III II+III Mixed K11-Lung U-26 III II Recombinant
K4-Heart U-7 III II Recombinant K11-Spln U-27 II+III II+III Mixed
K4-Spln U-11 III NT K11-Diaph U-28 I/II III Recombinant
K4-Diaph U-12 I/II II K12-Heart U-25 I/II I+II Mixed
K5-Spln II/III III II Recombinant K12-Spln U-29 I/II I+II Mixed
K6-Liver U-13 III I+II+III Mixed K13-Heart U-30 III I+II Recombinant/Mixed
K7-Heart U-14 I/II II K13-Diaph U-31 I/II I+II Mixed
K7-Spln U-15 II+III II+III Mixed K14-Heart U-32 I/II U-2
K7-Diaph U-16 III II Recombinant K14-Lung U-33 I/II II
K8-Heart U-15 NT II+III Mixed K14-Spln U-27 III II Recombinant
K8-Liver U-17 III I+II Recombinant/Mixed K15-Heart U-30 I/II U-2
K8-Diaph U-18 III I+II Recombinant/Mixed K16-Heart U-28 I/II II
K16-Lung U-33 I/II NT
U indicates non-archetypal allele. I, II and III refer to archetypal alleles from type I, II and III strains. NT indicates that the sample was not amplified.
doi:10.1371/journal.pone.0045147.t002
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cats in the area from which the macropods were sampled in this
study or from other areas of the State.
Our sampling design, involving direct detection and sequencing
of DNA from tissue samples, imposed a high demand for PCR
sensitivity and therefore limited the extent of multilocus genotyp-
ing that could be performed. We were able to obtain sequencing
data from only three loci; B1, SAG2 and SAG3. Nevertheless, the
allelic diversity at these three loci suggested that most genotypes
exist as minor variants of established archetypal lineages by the
accumulation of new mutations, particularly at the B1 locus, that
had subtly altered their genetic fingerprint. However, it was also
clear that for 14 ‘‘variants’’ recombination between archetypal
lineages followed by genetic drift was responsible for the
diversification of these strains. Specifically, atypical alleles (i.e.
different to archetypal type I, II or III strains) were found in 41
samples sequenced at the B1 locus, one sample at the SAG2 locus
and three samples at the SAG3 locus. Parameswaran et al. [10] also
found a large number of atypical alleles in T. gondii infecting
Australian wildlife, which they interpreted as a consequence of
genetic drift following the isolation of archetypal strains imported
into Australia during early European settlement. As in the present
study, Parameswaran et al. [10] also found evidence of recombi-
nation between these archetypal strains. These results suggest that
genetic diversity may be enhanced by regular cycles of outcrossing
between different strains of T. gondii infecting feral cats, as has been
suggested for felid definitive hosts involved in wildlife transmission
cycles in other areas of the world [8]. We should stress, however,
that our results are only suggestive; confirmation of the extent and
nature of genetic diversity in T. gondii infecting Australian wildlife
will require isolation, cloning and further sequencing studies using
a wider range of loci.
The most important finding from our study was that 14 of the
16 infected macropods harboured more than one genotype of T.
gondii, as indicated by the presence of dinucleotide peaks from
sequencing the single locus SAG2 and SAG3 genes in samples from
one organ or by the presence of different multilocus genotypes in
different organs of the same host. Although multiple infections
have previously been reported in naturally infected intermediate
hosts [20,29], they are often considered to be relatively rare events
because of the strong immunity developed by intermediate hosts to
primary infections with T. gondii [6]. The unique aspect of our
study is the extremely high rate of multiple infections in
intermediate hosts sampled from a defined geographic area.
These results may suggest something unusual about macropod
marsupials as hosts or the transmission cycle operating in this area
of arid Australia, or it may be a consequence of our sampling
design, which employed direct extraction and sequencing of T.
gondii DNA from a number of different organs from each host.
Direct detection of DNA, while it limits the number of loci
which can be amplified and examined, may be more likely to
detect multiple infections than traditional techniques of parasite
isolation, because of the potential for sampling bias arising from
competition between different strains when grown in vitro or in vivo
[7,13]. In addition, it is rare for studies of T. gondii in intermediate
hosts to sample a range of different organs. Of 13 macropods
which had T. gondii infections in more than one organ, all had
different genotypes of the parasite in these organs. There was also
some evidence of multiple infections in the same organ, but that
occurred in only 44% of samples. These results suggest that
examining only one organ for T. gondii may lead to an
underestimation of multiple infections. One of the disadvantages
of direct detection of DNA is the possibility of DNA contamination
producing spurious results. While this can never be ruled out
completely, we took a number of precautions to avoid contam-
ination. These included adding negative controls to every PCR
run and repeating DNA extractions from a number of tissue
samples, with the same genotypes being consistently detected.
These precautions, plus the level of genetic diversity found and
replicated in two different laboratories, give us confidence in the
robustness of our results.
The significance of multiple infections of T. gondii in interme-
diate hosts is the potential it provides for genetic exchange during
the sexual phase of the parasites life cycle. It has previously been
assumed that, because of the transient nature of infections in the
definitive host, and the apparent rarity of identifying multiple
infections in intermediate hosts, most infections within cats involve
only a single genotype of T. gondii derived from a single source of
prey [5,6,7]. This would lead to effective self fertilisation during
sexual reproduction and the perpetuation of a clonal population
structure. On the other hand, if intermediate hosts are usually
infected with a number of different genotypes of T. gondii, cross
fertilisation is more likely to occur during sexual reproduction,
which would break up clonal genotypes and lead to a more
panmictic population structure.
The results from our study suggest that, at least in sylvatic cycles
of transmission in Australia, multiple infections of intermediate
hosts may be very common. While the species of macropod
marsupials we sampled are too large to be preyed upon by feral
cats, the diversity of genotypes they contain is likely to be
indicative of a similar diversity in oocysts shed by cats. We
hypothesise that further studies of T. gondii in both feral cats and
small mammals preyed upon by cats in the area will find a large
proportion of multiple infections with different genotypes.
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